RTsafe Featured in Forbes

21February 2019

The Forbes article discusses RTsafe’s growth and how the company enhances the safety and efficiency in radiotherapy for brain cancer.

Click here to read the full article.

Explore our Products
& Services

29March 2023
RTsafe to exhibit at ESTRO 2023 in Vienna

Read More
13February 2023
RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by Fundación Instituto Valenciano de Oncología (IVO)

Read More

Request a quote